General Nieuws Oxurion Receives EUR 300,000 in the framework of the Atlas Funding Program Tenth tranche fully issued and paid-up EN FR maart 5, 2024
Nieuws Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas EN NL maart 4, 2024
Nieuws Regulated Transparency/Denominator Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC EN NL februari 29, 2024
Nieuws Regulated Transparency/Denominator Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC EN NL februari 23, 2024
Nieuws Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas EN NL februari 15, 2024
General Nieuws Oxurion Receives EUR 850,000 in the framework of the Atlas Funding Program Eight and ninth tranches fully issued and paid-up EN FR februari 14, 2024
Nieuws Regulated Transparency/Denominator Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC EN NL februari 9, 2024
Nieuws Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas EN NL februari 7, 2024
General Nieuws Oxurion Announces New Strategic Orientation to De-risk and Diversify EN NL FR januari 22, 2024
Nieuws Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas EN NL januari 19, 2024
Nieuws Regulated Transparency/Denominator Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC EN NL januari 17, 2024
Nieuws Regulated Transparency/Denominator Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC EN NL januari 12, 2024
General Nieuws Regulated Oxurion Avoids Bankruptcy, Announces Board and Management Changes and Enters into Binding Letter of Intent with its Main Creditor Atlas EN NL december 28, 2023
Nieuws Regulated Transparency/Denominator Oxurion Receives Transparency Notification from Negma Group EN NL december 6, 2023
Nieuws Regulated Transparency/Denominator Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC EN NL december 1, 2023
Nieuws Regulated Oxurion Discloses Topline Data from KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edema EN NL november 20, 2023
Nieuws Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas EN NL november 19, 2023
Nieuws Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas EN NL november 16, 2023
General Nieuws Oxurion Receives EUR 1.0 Million under Amended Atlas Funding Program Total of EUR 3.5 Million in Unconditional Funding Allowing Company to Reach Topline Data from KALAHARI Trial This Year EN november 16, 2023
